Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: A comparative study in rats

Inflammopharmacology

Volumn 14, Issue 3-4, 2006, Pages 163-169

  Tariq, Mohammad ^a   Al Moutaery, Meshal ^a   Elfaki, Ibrahim ^a   Arshaduddin, Mohammad ^a   Khan, Haseeb Ahmad ^b  

^a Prince Sultan Military Medical City   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cromoglycate; Duodenal ulcers; Gastric ulcers; Mast cells; Nedocromil

Indexed keywords

ALCOHOL; CROMOGLYCATE DISODIUM; GLUTATHIONE; INDOMETACIN; MERCAPTAMINE; NEDOCROMIL SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DUODENUM ULCER; FEMALE; GASTRIC ULCER BLEEDING; IMMOBILIZATION STRESS; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH MUCOSA LESION; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER;

EID: 33748499816     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-1524-6     Document Type: Article

References (78)

1. - secretion and duodenal ulcer formation in rats. Am J Physiol Gastroinvest Liver Physiol, 289, G753-G759.
2. Ali, A. T. (1995). The role of nitric oxide and sulphydryls in gastric mucosal protection induced by sodium cromoglycate in rats. J Pharm Pharmacol, 47, 739-43.
3. Allen, A., Sellers, L. A. and Bennett, M. K. (1987). The gastric mucosal epithelial barrier: Role of mucus and fibrin. Scand J Gastroenterol, 20, 1191-6.
4. Alton, E. W. and Norris, A. A. (1996). Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J Allergy Clin Immunol, 98, S102-S105.
5. Beck, P. L., Morris, G. P. and Wallace, J. L. (1989). Reduction of enthanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism. Can J Physiol Pharmacol, 67, 287-93.
6. Bell, A. E., Sellers, L. A., Allen, A. et al. (1985). Properties of gastric and duodenal mucus: Effects of proteolysis, disulfide reduction, bile, acid, ethanol and hypertonicity on mucus gel structure. Gastroenterology, 88, 269-80.
7. Bhargava, K. P., Gupta, M. B. and Tangri, K. K. (1973). Mechanism of ulcerogenic activity of indomethacin and ocyphenbutazone. Eur J Pharmacol, 22, 191-5.
8. Black, J. W., Duncan, W. A. M., Durant, G. J., Ganellin, C. R. and Parsons, E. M. (1972). Nature, 236, 385-90.
9. Braga, P. C., Mancini, L., Guffanti, E. E. et al. (1997). Effects of nedocromil sodium on the oxidative burst of polymorphonuclear leukocytes: comparison with salbutamol. Drug Exp Clin Res, 23, 33-8.
10. Brimblecombe, R. W., Duncan, W. A. M., Durant, G. J. et al. (1975). Cimetidien: a non-thiourea H2-receptor antagonist. J Int Med Res, 3, 86-92.
11. Caporali, R. and Luciano, S. (1986). Diffuse varioliform gastritis. Arch Dis Child, 61, 405-7.
12. Cheon, H. G., Lee, S. S., Lim, H. and Lee, D. H. (2001). Pharmacological properties of a newly synthesized H (+) /K (+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. Eur J Pharmacol, 411, 187-92.
13. Corne, S. J., Morrisey, S. M. and Woods, R. J. (1974). A method for the quantitative estimation of gastric barrier mucus. J Physiol (London), 242, 116-7.
14. De Benedictis, F. M., Tuteri, G., Pazzelli, P. et al. (1995). Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. J Allergy Clin Immunol, 96, 510-4.
15. Di Gioacchino, M., Pizzicannella, G., Fini, N. et al. (1990). Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. Allergy, 45, 161-6.
16. Elsbach, P. and Weiss, J. (1988). Phagocytosis of bacteria and phospholipi degradation. Biochim Biophys Acta, 947, 29-52.
17. Erkasap, S., Erkasap, N., Aral, E. et al. (2005). Mast cell stabilizator and antioxidant effects of epidermal growth factor (EGF) on gastric mucosal injury induced by ethanol in rats. Chin J Physiol, 48, 1-6.
18. Etienne, A., Thonier, F., Hecquet, F. and Braquet, P. (1988). Role of neutrophils in gastric damage induced by platelet activating factor. Naunyn Schmiedeberegs Arch Pharmacol, 338, 422-5.
19. Furuta, G. T., Wang, Z. S. and Wershil, B. K. (1998). Gastric inflammation during systemic anaphylaxis: neutrophil recruitment in stomach wall of mice does not require mast cell participation. Dig Dis Sci, 43, 2021-7.
20. Goa, K. L. and Monk, J. P. (1987). Enprotil: a preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer diseases. Drugs, 3, 539-59.
21. Goossens, J., Van Reempts, J. and Van Wauwe, J. P. (1987). Cytoprotective effects of disodium cormoglycate on rat stomach mucosa. Br J Pharmacol, 91, 165-9.
22. Grace, R. H., Gent, A. E. and Hellier, M. D. (1987). Comparative trial of sodium cormoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis. Gut, 28, 88-92.
23. Guardia, T., Guzman, J. A., Pestchanker, M. J. et al. (1994). Mucus synthesis and sulfhydryl groups in cytoprotection mediated by dehydroleucodine, a sequiterpene lactone. J Natl Prod, 57, 507-9.
24. + channel in bullfrog oxyntic cells. Am J Physiol Gastrointest Liver Physiol, 279, G400-G410.
25. Hernandez, L. A., Grisham, M. B., Twohigh, B. et al. (1987). Role of neutrophils in ischemia reperfusion induced microvasculars injury. Am J Physiol, 253, 699-703.
26. Huang, X. R., Chun Hui, C. W., Chen, Y. X. et al. (2001). Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology, 121, 619-30.
27. Hung, C. R. (1998). Low susceptibility of stress ulcer in diabetic rats: role of cholinergic gastric motility. Clin J Physiol, 41, 151-9.
28. Kasuya, Y., Urushiadani, T. and Okabe, S. (1979). Effects of various drugs and bagotomy on indomethacin induced gastric ulcers in the rat. Jpn J Pharmacol, 29, 670-3.
29. Kawakubo, K., Akiba, Y., Adelson, D. et al. (2005). Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats. Peptides, 26, 1580-9.
30. Kelly, K. D., Spooner, C. H. and Rowe, B. H. (2001). Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systemic review. Eur Respir J, 17, 39-45.
31. Kitahora, T. and Guth, P. H. (1987). Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology, 93, 810-7.
32. Laine, L. and Weinstein, W. M. (1998). Histology of alcoholic haemorrhagic gastritis: a prospective evaluation. Gastroenterology, 94, 1254-64.
33. Lal, S., Dorow, P. D., Venho, K. K. and Chatterjee, S. S. (1993). Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease. Chest, 104, 438-47.
34. Lee, M., Aldred, K., Lee, E. et al. (1992). Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in rats. Am J Physiol, 263, 920-6.
35. Lippman, W. (1974). Inhibition of indomethacin induced gastric ulceration in the rat by perorally administered synthetic and natural prostaglandin analogues. Prostaglandins, 7, 1-9.
36. Lorenz, W., Matejika, E., Schmal, A. et al. (1973). Comp Gen Pharmacol, 4, 229-50.
37. Makovec, F., Revel, L., Letari, O., Mennuni, L. and Impcciatore, M. (1999). Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK (B) receptor antagonist. Eur J Pharmacol, 369, 81-90.
38. McDaniel, N., Pace, A. J., Spiegel, S. et al. (2005). Role of Na-K-2Cl cotransporter-1 in gastric secretion of nonacidic fluid and pepsinogen. Am J Physiol Gastrointest Liver Physiol, 289, G550-G560.
39. Moots, R. J., Prouse, P. and Gumpel, J. M. (1988). Near fatal eosinophilic gastroenteritis responding to oral sodium chromoglycate. Gut, 29, 1282-5.
40. Nakajima, S., Bamba, N. and Hattori, T. (2004). Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther, 20, 165-70.
41. Natale, G., Lazzeri, G., Blandizzi, C. et al. (2001). Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol, 174, 17-26.
42. Nicol, A. K., Thomas, M. and Wilson, J. (1981). Inhibition of gastric acid secretion by sodium cromoglycate and FPL 52694. J Pharm Pharmacol, 33, 554-6.
43. Nishida, A., Akuzawa, S., Kobayashi, A. et al. (1993). Pharmacological profile of YMO22, a potent and selective gastrin/cholecystokinin-B receptor antagonist. Jpn J Pharmacol, 61, 194.
44. Nishida, A., Takinami, Y., Yuki, H. et al. (1994). YMO22 {(R)-1-(2,3-dihydro-1-(2-methyl-phenacyl)-2-oxo-5-phenyl-1H-14-benzodiazepin-3- yl)-3-(3-methylphenyl)-urea}, a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastricduodenal lesions in rats. J Pharmacol Exp Ther, 270, 1256-61.
45. Ogle, C. W. and Hui, S. C. (1995). The influence of peripheral or central administration of ondansetron on stress-induced gastric ulceration in rats. Experientia, 51, 786-9.
46. Ohta, Y., Kobayashi, T. Inui, K., Yoshino, J. and Nakazawa, S. (2003). Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. J Pharmacol Sci, 93, 337-46.
47. Okayama, Y., Benyon, R. C., Rees, P. H. et al. (1992). Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy, 22, 401-9.
48. Otamiri, T. and Tagesson, C. (1989). Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am J Surg, 157, 562-5.
49. Owen, W. G. (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem, 106, 207-12.
50. Patel, H. M., Santani, D. D. and Goswami, S. G. (2001). Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. Pharmacology, 63, 154-9.
51. Pendley, C. E., Fitzpatrick, L. R., Capolino, A. J. et al. (1995). RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. J Pharmacol Exp Ther, 273, 1015-22.
52. Pendley, C. E., Fitzpatrick, L. R., Ewing, R. W. et al. (1992). The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat. J Pharmacol Exp Ther, 265, 1348-54.
53. Penissi, A.B., Rudolph, M. I. and Piezzi, R. S. (2003). Role of mast cells in gastrointestinal mucosal defense. Biocell, 27, 163-72.
54. Piqueras, L., Corpa, J. M., Martinez, J. and Martinez, V. (2003). Gastric hypersecretion associated to iodoacetamide-induced mild gastritis in mice. Naunyn Schmiedebergs Arch Pharmacol, 367, 140-50.
55. Robuschi, M., Gambaro, G., Sestini, P. et al. (1997). Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Am J Respir Crit Care Med, 155, 1461-6.
56. Salim, A. S. (1992). Sulfhydryl-containing agents: a new approach to the problem of refractory peptic ulceration. Pharmacology, 45, 301-6.
57. Schiantarelli, P., Cadel, S. and Folco, G. C. (1984). Gastroprotective effects of mornifulmate, an esterified anti-inflammatory drug. Arzneimittelforschung, 34, 885-90.
58. Shay, H., Kumarove, S. A., Fels, S. A. et al. (1945). A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology, 5, 43-61.
59. - channels in rabbit gastric mucosa. Am J Physiol Cell Physiol, 280, C1599-C1606.
60. Shimizu, N., Watanabe, T., Arakawa, T. et al. (2000). Pentoxifylline accelerates gastric ulcer healing in rats: roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing. Digestion, 61, 157-64.
61. Shindo, Y., Konagaya, M., Harasawa, S., Miwa, T. and Osamura, Y. (1997). The role of histamine in ethanol-induced gastric mucosal injury in the rat. Tokai J Exp Clin Med, 22, 59-64.
62. - exchange in the villous epithelium of intact murine duodenum. Am J Physiol Gastrointest Liver Physiol, 288, G1241-G1251.
63. Slomiany, B. L., Piasek, A., Sarosiek, J. et al. (1985). The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand J Gastroenterol, 20, 1191-6.
64. Spezia, E., Del Col, G., Richelli, C., Sette, L. and Boner, A. L. (1993). Nedocromil sodium vs. sodium cromoglycate pressurized aerosol in the prevention of bronchoconstriction induced by ultrasonic nebulized distilled water in asthmatic children. Pediatr Pulmonol, 16, 243-7.
65. Szabo, S. (1978). Animal model of human disease. Cysteamine induced acute and chronic duodenal ulcer in the rat. Am J Pathol, 93, 273-6.
66. Szabo, S., Reynolds, E. S., Lichtenberger, L. M., Haith, L. R. and Dzau, V. J. (1977). Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats. Res Commun Chem Pathol Pharmacol, 16, 311-23.
67. Tabuchi, Y., Kawarabayashi, K. and Furuhama, K. (1994). Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats. Agents Actions, 41, 21-4.
68. Takeuchi, K., Nishiwaki, H. and Okabe, S. (1986). Cytoprotective action of mast cell stabilizers against ethanol-induced gastric lesions in rats. Jpn J Pharmacol, 42, 297-307.
69. Takeuchi, Y., Kitano, S., Bandoh, T. et al. (2003). Accelaration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? Eur Surg Res, 35, 75-80.
70. Tanigaki, K., Sato, T., Tanaka, Y. et al. (2002). BE-18591 as a new H (+) /Cl (-) symport ionophore that inhibits immunoproliferation and gastritis. FEBS Lett, 524, 37-41.
71. Tariq, M., Parmar, N. S. and Aqeel, A. M. (1987). Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats. J Pharmacol Exp Ther, 241, 602-7.
72. Vaananen, P. M., Meddings, J. B. and Wallace, J. L. (1991). Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol, 261, G470-G475.
73. Valcavi, U., Caponi, R., Brambilla, A. et al. (1992). Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20- bismorprotanoic acid in experimental animals. Arzneim Forsch, 32, 657-63.
74. Verin, P. H., Dicker, I. D. and Mortemousque, B. (1999). Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. Clin Exp Allergy, 29, 529-36.
75. Vugman, I. and Rocha, S. M. (1996). Biological determination of histamine in living tissues and body fluids, in: Handboook of Experimental Pharmacology, Rocha, S. (Ed), pp 81-115, Vol. XVIII, Part I. Springer-Verlag, Berlin.
76. Wallace, J. L. and Whittle, B. J. R. (1986). Role of mucus in the repair of gastric epithelial damage in the rat. Gastroenterology, 91, 603-11.
77. Watanabe, T., Arakawa, T., Tominaga, K. et al. (2000). Neutrophil accumulation in development of gastric ulcer induced by submucosal ingestion of endothelin-1 in rats. Dig Dis Sci, 45, 880-8.
78. Yamamoto, S., Kaneko, H., Konagawa, T. et al. (2001). Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori positive peptic ulcer patients. Helicobacter, 6, 136-45.